Version 1.0
Program
PROJECT STRANDSHIFT-CMF
Parent Program
PROJECT STRANDSHIFT
Classification
Emotional Neuroscience × Psychoneuroimmunology × Trauma-Epigenomics × Neuroimmune Regulation × Conscience Mind Research
Objective
To map the emotional regulation systems that influence stress recovery, neuroimmune activation, behavioral adaptation, resilience capacity, and disease-modifier biology in Huntington disease and HTT-associated neurodegenerative disorders.
I. CORE EMOTIONAL REGULATION HYPOTHESIS
Emotional regulation is a disease-modifier system that may influence PROJECT STRANDSHIFT outcomes through the following pathway:
Emotional Appraisal
↓
Limbic Activation
↓
HPA-Axis Signaling
↓
Autonomic Regulation
↓
Neuroimmune Activation
↓
Mitochondrial Stress
↓
DNA Injury Burden
↓
Apoptosis Susceptibility
↓
Clinical Progression
Within CMF, emotional regulation belongs primarily to the Emotion domain but interacts directly with Awareness, Embodiment, Energy, Time, and Transformation.
II. EMOTIONAL REGULATION SYSTEMS MAP
System | Function | STRANDSHIFT Relevance |
Amygdala | threat detection, fear processing | stress reactivity and trauma response |
Hippocampus | context memory, stress feedback | emotional memory and cortisol regulation |
Prefrontal Cortex | top-down regulation | impulse control and affect regulation |
Anterior Cingulate Cortex | conflict monitoring | emotional decision-making |
Insula | interoception | bodily awareness of emotion |
Hypothalamus | HPA-axis initiation | cortisol and autonomic output |
III. EMOTIONAL BIOMARKER ATLAS
Cortisol
Primary stress hormone reflecting HPA-axis activation. In STRANDSHIFT, persistent cortisol disruption may indicate emotional stress burden and potential neuroimmune amplification.
ACTH
Pituitary stress-output marker. Elevated ACTH may indicate upstream emotional-arousal activation.
CRH
Hypothalamic stress-initiation signal. CRH links emotional threat perception to endocrine stress physiology.
DHEA
Stress-buffering neurosteroid. Higher DHEA relative to cortisol may reflect emotional resilience capacity.
IL-6
Stress-sensitive inflammatory cytokine. IL-6 may link emotional dysregulation to neuroimmune activation.
TNF-α
Inflammatory mediator associated with chronic immune activation and neuronal stress.
IL-1β
Innate immune cytokine associated with microglial activation and sickness behavior.
IV. EMOTIONAL GENE-CLASS ATLAS
Gene | Function | Emotional Regulation Role |
SLC6A4 | serotonin transport | mood regulation and affect stability |
HTR1A | serotonin receptor | anxiety modulation and emotional recovery |
HTR2A | serotonin receptor | emotional perception and salience |
COMT | dopamine metabolism | executive-emotional control |
MAOA | monoamine degradation | emotional intensity modulation |
BDNF | neuroplasticity | resilience and emotional learning |
NTRK2 | BDNF receptor | adaptive emotional reconsolidation |
FKBP5 | glucocorticoid receptor regulation | trauma-related stress sensitivity |
NR3C1 | glucocorticoid receptor | cortisol feedback regulation |
CRHR1 | CRH receptor | threat response and anxiety physiology |
OXTR | oxytocin receptor | attachment and social buffering |
AVPR1A | vasopressin receptor | social-emotional memory |
V. CMF EMOTIONAL DOMAINS
1. Emotional Awareness
The capacity to identify, label, and interpret emotional states. Impairment may increase stress burden by preventing accurate self-regulation.
2. Emotional Reactivity
The intensity and speed of emotional activation. High reactivity may amplify HPA-axis output and inflammatory signaling.
3. Emotional Recovery
The ability to return to baseline after stress. Slow recovery may increase cumulative cortisol and cytokine exposure.
4. Emotional Flexibility
The ability to shift emotional state according to context. Reduced flexibility may contribute to perseveration, anxiety, irritability, and behavioral rigidity.
5. Social-Emotional Regulation
The ability to regulate emotion through relationships, attachment, empathy, and social support.
6. Trauma-Emotional Encoding
The long-term storage of emotionally significant adversity through neuroendocrine, epigenomic, and immune programming pathways.
VI. TRAUMA–EMOTIONAL REGULATION CONVERGENCE
Trauma may alter emotional regulation by reshaping stress-response systems.
Trauma Exposure
↓
Amygdala Sensitization
↓
HPA-Axis Dysregulation
↓
FKBP5 / NR3C1 Remodeling
↓
Cortisol Instability
↓
Inflammatory Priming
↓
Reduced Emotional Recovery
↓
Higher Neuroimmune Burden
In PROJECT STRANDSHIFT, this pathway is treated as a disease-modifier hypothesis, not as a primary disease cause.
VII. EMOTION–NEUROIMMUNE CONVERGENCE
Emotional dysregulation may influence neuroimmune activation through stress-mediated cytokine pathways.
Emotional Stress
↓
Sympathetic Activation
↓
Monocyte / Microglial Priming
↓
IL-6, TNF-α, IL-1β Elevation
↓
Synaptic Stress
↓
Cognitive and Behavioral Dysregulation
This model supports integration with the Neuroimmune Stress Atlas.
VIII. EMOTION–DNA INJURY CONVERGENCE
The STRANDSHIFT theoretical model proposes that prolonged emotional stress may indirectly influence DNA injury burden through oxidative and mitochondrial mechanisms.
Emotional Dysregulation
↓
Cortisol Dysregulation
↓
Mitochondrial Stress
↓
ROS Generation
↓
8-OHdG Elevation
↓
γH2AX / 53BP1 Activation
↓
DNA Repair Burden
This remains a testable hypothesis requiring longitudinal biomarker validation.
IX. EMOTION–VIRAL MIMICRY CONVERGENCE
Emotional stress may contribute to viral-mimicry susceptibility indirectly through immune dysregulation and DNA injury.
Emotional Stress
↓
Neuroimmune Activation
↓
DNA Injury / Cytosolic DNA
↓
cGAS-STING Activation
↓
IFN-I Signaling
↓
OAS1, MX1, ISG15, IFIT1 Elevation
This pathway does not imply viral infection. It represents sterile antiviral-like signaling.
X. EMOTION–APOPTOSIS CONVERGENCE
Persistent emotional stress may contribute to apoptosis vulnerability when combined with HTT pathology, DNA injury, mitochondrial dysfunction, and neuroimmune activation.
Neuroimmune Stress
↓
Mitochondrial Dysfunction
↓
TP53 Activation
↓
BAX / BCL2 Shift
↓
Caspase-9
↓
Caspase-3
↓
Apoptotic Commitment
XI. CMF EMOTIONAL REGULATION INDICES
CMF-ER1: Emotional Awareness Score
Measures emotional identification, insight, interoception, and self-monitoring.
CMF-ER2: Emotional Reactivity Score
Measures intensity, frequency, and duration of emotional activation.
CMF-ER3: Emotional Recovery Score
Measures return-to-baseline capacity after stress.
CMF-ER4: Social-Emotional Buffering Score
Measures attachment, social support, empathy, and relational stability.
CMF-ER5: Trauma-Emotional Burden Score
Measures adversity exposure, trauma-related stress markers, FKBP5/NR3C1 signals, and cortisol instability.
CMF-ER6: Neuroimmune Emotional Stress Score
Integrates emotional dysregulation with IL-6, TNF-α, IL-1β, CRP, and microglial activation markers.
CMF-ER Integrated Emotional Regulation Index
Composite emotional regulation capacity across awareness, reactivity, recovery, social buffering, trauma burden, and neuroimmune stress.
XII. PRIMARY RESEARCH QUESTIONS
Question 1
Can emotional dysregulation predict neuroimmune activation in HTT mutation carriers?
Question 2
Does trauma-associated emotional encoding alter cortisol rhythm and inflammatory burden?
Question 3
Can emotional recovery capacity predict resilience against cognitive and behavioral decline?
Question 4
Does emotional stress correlate with DNA injury markers such as 8-OHdG, γH2AX, and 53BP1?
Question 5
Can improved emotional regulation reduce neuroimmune stress indices?
Question 6
Which emotional regulation domains are most protective against disease-amplification states?
Question 7
Can CMF emotional regulation profiling improve patient stratification for STRANDSHIFT studies?
XIII. CONCLUSION
The CMF Emotional Regulation Atlas establishes emotional regulation as a measurable disease-modifier system within PROJECT STRANDSHIFT-CMF. It integrates limbic circuitry, HPA-axis signaling, trauma-epigenomics, neuroimmune activation, mitochondrial stress, DNA injury, viral-mimicry susceptibility, apoptosis risk, and resilience capacity into a unified emotional systems framework. Within STRANDSHIFT, emotional dysregulation does not cause Huntington disease, but may influence progression, symptom burden, adaptation, and resilience through psychoneuroimmunological mechanisms.